Crystal Pharmatech (United States)

Crystal Pharmatech (United States) is the U.S.-based operation of Crystal Pharmatech, a contract development and manufacturing organization (CDMO) and contract research organization (CRO) that positions itself as a global partner for solid-state research and formulation development. The U.S. entity is recorded as a company in Cranbury, New Jersey, and operates under the Crystal Pharmatech brand alongside the parent group, Crystal Pharmatech Co., Ltd. Its website presents a broad, integrated service portfolio spanning small molecules, biologics, and nucleic-acid modalities, marketed to pharmaceutical and biotechnology clients that need to move drug candidates from early development through clinical and commercial supply. The company's core small-molecule offering is organized around a "First-Time-Right 3-STEP Approach" that covers developability assessment, API form and solid-state research, and formulation development. Specific capabilities include solid-state characterization, pKa/LogP/LogD measurement, stability and solubility studies, in-silico PBPK modeling, solid form screening and selection, absolute structure determination, solid-state NMR, crystallization development, chiral separation, pre-formulation studies, excipient compatibility, amorphous solid dispersions, and oral solid dosage form development. The company also lists pediatric formulation work such as mini-tablets, analytical research and quality control, clinical and commercial manufacturing, and clinical supply services. Beyond small molecules, Crystal Pharmatech has built out service lines for newer modalities. Crystal Bio Solutions covers biologics characterization and CMC analytics, bioanalytical and biomarker services, and quantitative clinical pharmacology. Crystal NAX addresses nucleic-acid-based programs with DNA synthesis, RNA synthesis, LNP formulation services, analytical and characterization services, and early-phase manufacturing. The company also offers catalogue products and technical platforms for oral dosage forms, and it maintains a knowledge hub, webinar series, and news/events channels aimed at its client base. As a U.S. entity, Crystal Pharmatech (United States) gives the group a local presence in one of the world's largest pharmaceutical markets, complementing the parent organization's global CDMO/CRO footprint. The brand's positioning emphasizes integrated, science-driven development services that help clients reduce risk and accelerate timelines from candidate selection to clinic and market. Because the available evidence is largely the company's own website and a Wikidata entry identifying it as a company in Cranbury, United States, details such as exact founding year, ownership structure, and financial status are not established here.

Crystal Pharmatech (United States) is the U.S. operation of Crystal Pharmatech, a company that has built its identity around solid-state research and formulation development for the pharmaceutical industry. The U.S. entity is identified in public records as a company located in Cranbury, New Jersey, and it operates under the Crystal Pharmatech brand together with the parent organization, Crystal Pharmatech Co., Ltd. The company's own website presents its history as part of the "About Us" section, indicating that the group has grown from its scientific roots into a global CDMO/CRO offering. The brand's development narrative is closely tied to its technical specialization. Crystal Pharmatech has organized its small-molecule business around a "First-Time-Right 3-STEP Approach," which structures services into developability assessment, API form and solid-state research, and formulation development. This framework reflects the company's origins in solid-state chemistry and crystallization science, areas where it offers solid form screening and selection, absolute structure determination, solid-state NMR, crystallization development, and chiral separation. Over time, the service portfolio expanded into pre-formulation studies, amorphous solid dispersions, oral solid dosage forms, pediatric mini-tablets, analytical research and quality control, and clinical and commercial manufacturing. A significant phase in the company's evolution has been its expansion beyond small molecules into biologics and nucleic-acid-based modalities. The Crystal Bio Solutions line covers biologics characterization and CMC analytics, bioanalytical and biomarker services, and quantitative clinical pharmacology. The Crystal NAX line addresses DNA synthesis, RNA synthesis, LNP formulation services, analytical and characterization services, and early-phase manufacturing. These additions position the group to serve developers of modern therapeutic modalities, including mRNA and other nucleic-acid therapeutics that rely on lipid nanoparticle delivery. The U.S. entity, Crystal Pharmatech (United States), gives the group a presence in the U.S. pharmaceutical market, which is among the largest in the world. Its Cranbury, New Jersey location places it within the U.S. Northeast pharmaceutical and biotechnology corridor. The company also maintains client-facing resources such as a knowledge hub, webinar series, and news and events pages, which support its positioning as a scientific partner rather than only a service provider. Because the available evidence consists primarily of the company's own website and a Wikidata entry, the precise founding date of the U.S. entity, its ownership structure, and its financial or listing status are not established in this dossier. What is clear from the evidence is that Crystal Pharmatech (United States) operates as part of a global CDMO/CRO brand focused on integrated drug development services from solid-state research through clinical and commercial supply.

Global CDMO & CRO for solid-state and formulation services, with integrated small-molecule, biologics, and nucleic-acid capabilities.

• First-Time-Right 3-STEP Approach

  A structured small-molecule development framework covering developability assessment, API form and solid-state research, and formulation development.

• Solid-State Characterization/FAST

  Solid-state characterization services including pKa/LogP/LogD measurements, stability and solubility studies, and in-silico PBPK modeling and simulation.

• Solid Form Screening and Selection

  Screening and selection of solid forms, absolute structure determination and crystal identification, and solid-state NMR analysis.

• Crystallization Development Services

  Crystallization development and chiral separation services.

• Pre-formulation Studies

  Comprehensive physicochemical property evaluation, excipient selection and compatibility studies, formulations for PK/efficacy/tox studies, and animal dosing vehicle selection.

• Amorphous Solid Dispersions

  Amorphous solid dispersion development using spray drying and hot-melt extrusion.

• First-Time-Right Formulation Development

  Oral solid dosage forms, amorphous solid dispersion, and pediatric formulation (mini-tablet).

• Analytical Research and Quality Control

  Analytical research and quality control services supporting development and manufacturing.

• Clinical and Commercial Manufacturing

  Clinical and commercial manufacturing services, including clinical supply.

• Crystal Bio Solutions

  Biologics characterization and CMC analytics, bioanalytical and biomarker services, and quantitative clinical pharmacology (QCP).

• Crystal NAX

  DNA synthesis, RNA synthesis, LNP formulation services, analytical and characterization services, and early-phase manufacturing.

• Catalogue Products

  Catalogue products offered alongside the company's service lines.

• Technical Platforms for Oral Dosage Forms

  Technical platforms supporting oral dosage form development.

1. 1Crystal Pharmatech | Global CDMO & CRO for Solid-State & Formulationcrystalpharmatech.com
2. 2About Crystal Pharmatech | Leading Solid-State Research CRO/CDMOcrystalpharmatech.com
3. 3Our History - Crystal Pharmatech Co., Ltd.crystalpharmatech.com
4. 4Company News | Crystal Pharmatechcrystalpharmatech.com
5. 5Crystal Pharmatech (United States) - Wikidatawikidata.org